Conceptual image of DNA being injected with a syringe.

Our Capabilities

  • Transient transfected retroviral (RVV) and lentiviral (LVV) vectors
  • Stable retrovirus-producing cell lines
  • Immunotherapy platforms: CAR-T, TCR-T, NK cells, macrophages
  • CD34+ stem cell gene correction using lentiviral vectors
  • ...and more